Rovas, Alexandros
Sackarnd, Jan
Rossaint, Jan
Kampmeier, Stefanie
Pavenstädt, Hermann
Vink, Hans
Kümpers, Philipp https://orcid.org/0000-0001-9929-0703
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KU 2873/3-1, RO 4537/5-1)
Westfälische Wilhelms-Universität Münster
Article History
Received: 12 October 2020
Accepted: 1 March 2021
First Online: 19 March 2021
Declarations
:
: The study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the General Medical Council Westfalen-Lippe and the WWU Münster, Germany (file number: amendment to 2016–073-f-S). Informed consent was obtained.
: Consent for publication has been obtained. Written informed consent has been obtained from all identifiable individuals.
: AR, JS, JR, SK, HP, and PK declare that they have no competing interests. HV is Chief Science Officer of GlycoCheck™ BV, The Netherlands. GlycoCheck™ and MVHS™ are trademarks registered by Microvascular Health Solutions LLC (Alpine, UT, United States).